Armata Pharmaceuticals (ARMP)
Develops bacteriophage cocktails for serious antibiotic-resistant bacterial infections.
$4.20
After hours−0.02 (−0.47%)
At close$4.22(−0.94%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 13.48% | 5.01M shares | |
|---|---|---|---|
| 54 holders · as of Jun 30, 2026 | |||
| Other | 86.52% | 32.17M shares | |
| remainder | |||
37.18M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
54 holders · 5.01M shares · 20 new positions · 37 increased · 3 reduced · 11 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Madison Asset Management, LLC | 2.11M | 5.67% | −500 | Aug 10, 2026 |
| BlackRock, Inc. | 560.0K | 1.51% | +494.9K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 488.0K | 1.31% | +121.9K | Aug 13, 2026 |
| Millennium Management LLC | 470.5K | 1.27% | +212.5K | Aug 14, 2026 |
| Geode Capital Management, LLC | 270.6K | 0.73% | +156.0K | Aug 12, 2026 |
| Dauntless Investment Group, LLC | 203.9K | 0.55% | +113.3K | Aug 13, 2026 |
| State Street Corp | 129.6K | 0.35% | +78.8K | Aug 7, 2026 |
| Northern Trust Corp | 89.8K | 0.24% | +65.1K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Innoviva, Inc.incl. Innoviva Strategic Opportunities LLC | 82.70% | 55.47M | 13D | May 13, 2026 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.